Sfoglia per Rivista EUROPEAN HEART JOURNAL
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2022-01-01 Katja, Z; Jacob, Th; Marta, De; Bo Gregers, Winkel; Elijah R., Behr; Nico A., Blom; Philippe, Charron; Domenico, Corrado; Nikolaos, Dagres; Christian de, Chillou; Lars, Eckardt; Tim, Friede; Kristina H., Mélèze Hocini; Pier D., Lambiase (United Kingdom); Eloi Marijon, (France); Jose L., Merino (Spain); Petr, Peichl; Silvia, G.; Tobias Reichlin, (Switzerland); Jeanette Schulz-Menger, (Germany); Christian, Sticherling; Stylianos, Tzeis; Axel, Verstrael; Volterrani, M
A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial)
2015-01-01 Anker, Sd; Coats, Aj; Cristian, G; Dragomir, D; Pusineri, E; Piredda, M; Bettari, L; Dowling, R; Volterrani, M; Kirwan, Ba; Filippatos, G; Mas, Jl; Danchin, N; Solomon, Sd; Lee, Rj; Ahmann, F; Hinson, A; Sabbah, Hn; Mann, Dl
Biventricular endomyocardial biopsy findings in patients with Brugada syndrome
2003-01-01 Pieroni, M; Chimenti, C; Bellocci, F; Russo, Ma; Maseri, A; Frustaci, A.
Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality.
2002-01-01 Ceconi, C; Ferrari, R; Bachetti, T; Opasich, C; Volterrani, M; Colombo, B; Parrinello, G; Corti, A
Circulating microRNAs are new and sensitive biomarkers of myocardial infarction
2010-01-01 D'Alessandra, Y; Devanna, P; Limana, F; Straino, S; Di Carlo, A; Brambilla, Pg; Rubino, M; Carena, Mc; Spazzafumo, L; De Simone, M; Micheli, B; Biglioli, P; Achilli, F; Martelli, F; Maggiolini, S; Marenzi, G; Pompilio, G; Capogrossi, Mc.
Coxsackie virus heart disease: 15 years after.
1988-01-01 Levi, G; Scalvini, S; Volterrani, M; Marangoni, S; Arosio, G; Quadri, A
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control
2006-01-01 Santilli, F; Devangelio, E; Formoso, G; Ferroni, P; Bucciarelli, L; Ciabattoni, G; Consoli, A; Davi, G
Increased BNP secretion is a marker of disease progression in hypertrophic cardiomyopathy
2005-01-01 Pieroni, M.; Chimenti, Cristina; Sanna, T.; Verardo, R.; Russo, MATTEO ANTONIO; Maseri, A.; Frustaci, Andrea
Increased oxydative stress contribute to cardiomyocyte dysfunction in patients with Fabry disease cardiomyopathy
2011-01-01 Chimenti, C; Vulpis, E; Cudemo, G; Tafani, M; Villanova, L; Verardo, R; Russo, Ma; Frustaci, A.
Intramyocyte detection of Epstein Barr virus genome by laser capture microdissection in patients with inflammatory cardiomyopathy
2004-01-01 Chimenti, C; Pieroni, M; Russo, A; Verardo, R; Russo, Ma; Maseri, A; Frustaci, A.
Long-term clinical-pathologic results of enzyme replacement therapy in pre-hypertrophic Fabry disease cardiomyopathy
2023-01-01 Frustaci, A; Verardo, R; Galea, N; Alfarano, M; Magnocavallo, M; Scialla, R; Sansone, L; Belli, M; Cristina, M; Frustaci, E; Russo, M A; Chimenti, C
Myocardial production of Chromogranin A: a new regulatory peptide of myocyte function
2005-01-01 Pieroni, M.; Chimenti, Cristina; Curnis, F.; Colombo, B.; Russo, MATTEO ANTONIO; Maseri, A.; Corti, A.; Frustaci, Andrea
Pathology and function of conduction tissue in Fabry disease cardiomyopathy
2015-01-01 Frustaci, A; Morgante, E; Russo, Ma; Scopelliti, F; Grande, C; Verardo, R; Franciosa, P; Chimenti, C.
Predictors of exercise capacity in chronic heart failure
1994-01-01 Volterrani, M; Clarck, A L; Ludman, P F; Swan, J W; Adamaoupolos, S; Pipoli, M; Coats, A J
Predictors of exercise capacity in chronic heart failure.
1994-01-01 Volterrani, M; Clark, Al; Ludman, Pf; Swan, Jw; Adamopoulos, S; Piepoli, M; Coats, Aj
Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy; the TIMIC study
2009-01-01 A, Frustaci; Russo, M.; C, Chimenti
Structural myocardial abnormalities in asymptomatic family members with Brugada syndrome and SNC5A gene mutation
2009-01-01 Frustaci, A; Russo, Ma; C., Chimenti
The histologic substrate of atrial biopsy in patients with lone atrial fibrillation.
1996-01-01 Frustaci, A; Chimenti, C; Morgante, E; Russo, Ma; Maseri, A
The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure.
1997-01-01 Anker, Sd; Swan, Jw; Volterrani, M; Chua, Tp; Clark, Al; Poole-Wilson, Pa; Coats, Aj
Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
2004-01-01 Vitale, C; Wajngaten, M; Sposato, B; Gebara, O; Rossini, P; Fini, M; Volterrani, M; Rosano, Gm
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death | 1-gen-2022 | Katja, Z; Jacob, Th; Marta, De; Bo Gregers, Winkel; Elijah R., Behr; Nico A., Blom; Philippe, Charron; Domenico, Corrado; Nikolaos, Dagres; Christian de, Chillou; Lars, Eckardt; Tim, Friede; Kristina H., Mélèze Hocini; Pier D., Lambiase (United Kingdom); Eloi Marijon, (France); Jose L., Merino (Spain); Petr, Peichl; Silvia, G.; Tobias Reichlin, (Switzerland); Jeanette Schulz-Menger, (Germany); Christian, Sticherling; Stylianos, Tzeis; Axel, Verstrael; Volterrani, M | |
| A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial) | 1-gen-2015 | Anker, Sd; Coats, Aj; Cristian, G; Dragomir, D; Pusineri, E; Piredda, M; Bettari, L; Dowling, R; Volterrani, M; Kirwan, Ba; Filippatos, G; Mas, Jl; Danchin, N; Solomon, Sd; Lee, Rj; Ahmann, F; Hinson, A; Sabbah, Hn; Mann, Dl | |
| Biventricular endomyocardial biopsy findings in patients with Brugada syndrome | 1-gen-2003 | Pieroni, M; Chimenti, C; Bellocci, F; Russo, Ma; Maseri, A; Frustaci, A. | |
| Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality. | 1-gen-2002 | Ceconi, C; Ferrari, R; Bachetti, T; Opasich, C; Volterrani, M; Colombo, B; Parrinello, G; Corti, A | |
| Circulating microRNAs are new and sensitive biomarkers of myocardial infarction | 1-gen-2010 | D'Alessandra, Y; Devanna, P; Limana, F; Straino, S; Di Carlo, A; Brambilla, Pg; Rubino, M; Carena, Mc; Spazzafumo, L; De Simone, M; Micheli, B; Biglioli, P; Achilli, F; Martelli, F; Maggiolini, S; Marenzi, G; Pompilio, G; Capogrossi, Mc. | |
| Coxsackie virus heart disease: 15 years after. | 1-gen-1988 | Levi, G; Scalvini, S; Volterrani, M; Marangoni, S; Arosio, G; Quadri, A | |
| Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control | 1-gen-2006 | Santilli, F; Devangelio, E; Formoso, G; Ferroni, P; Bucciarelli, L; Ciabattoni, G; Consoli, A; Davi, G | |
| Increased BNP secretion is a marker of disease progression in hypertrophic cardiomyopathy | 1-gen-2005 | Pieroni, M.; Chimenti, Cristina; Sanna, T.; Verardo, R.; Russo, MATTEO ANTONIO; Maseri, A.; Frustaci, Andrea | |
| Increased oxydative stress contribute to cardiomyocyte dysfunction in patients with Fabry disease cardiomyopathy | 1-gen-2011 | Chimenti, C; Vulpis, E; Cudemo, G; Tafani, M; Villanova, L; Verardo, R; Russo, Ma; Frustaci, A. | |
| Intramyocyte detection of Epstein Barr virus genome by laser capture microdissection in patients with inflammatory cardiomyopathy | 1-gen-2004 | Chimenti, C; Pieroni, M; Russo, A; Verardo, R; Russo, Ma; Maseri, A; Frustaci, A. | |
| Long-term clinical-pathologic results of enzyme replacement therapy in pre-hypertrophic Fabry disease cardiomyopathy | 1-gen-2023 | Frustaci, A; Verardo, R; Galea, N; Alfarano, M; Magnocavallo, M; Scialla, R; Sansone, L; Belli, M; Cristina, M; Frustaci, E; Russo, M A; Chimenti, C | |
| Myocardial production of Chromogranin A: a new regulatory peptide of myocyte function | 1-gen-2005 | Pieroni, M.; Chimenti, Cristina; Curnis, F.; Colombo, B.; Russo, MATTEO ANTONIO; Maseri, A.; Corti, A.; Frustaci, Andrea | |
| Pathology and function of conduction tissue in Fabry disease cardiomyopathy | 1-gen-2015 | Frustaci, A; Morgante, E; Russo, Ma; Scopelliti, F; Grande, C; Verardo, R; Franciosa, P; Chimenti, C. | |
| Predictors of exercise capacity in chronic heart failure | 1-gen-1994 | Volterrani, M; Clarck, A L; Ludman, P F; Swan, J W; Adamaoupolos, S; Pipoli, M; Coats, A J | |
| Predictors of exercise capacity in chronic heart failure. | 1-gen-1994 | Volterrani, M; Clark, Al; Ludman, Pf; Swan, Jw; Adamopoulos, S; Piepoli, M; Coats, Aj | |
| Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy; the TIMIC study | 1-gen-2009 | A, Frustaci; Russo, M.; C, Chimenti | |
| Structural myocardial abnormalities in asymptomatic family members with Brugada syndrome and SNC5A gene mutation | 1-gen-2009 | Frustaci, A; Russo, Ma; C., Chimenti | |
| The histologic substrate of atrial biopsy in patients with lone atrial fibrillation. | 1-gen-1996 | Frustaci, A; Chimenti, C; Morgante, E; Russo, Ma; Maseri, A | |
| The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. | 1-gen-1997 | Anker, Sd; Swan, Jw; Volterrani, M; Chua, Tp; Clark, Al; Poole-Wilson, Pa; Coats, Aj | |
| Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease. | 1-gen-2004 | Vitale, C; Wajngaten, M; Sposato, B; Gebara, O; Rossini, P; Fini, M; Volterrani, M; Rosano, Gm |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile